ASO Author Reflections: PTTG1 Protein Expression in Adrenocortical Carcinoma

  • Minerva Angélica Romero Arenas
  • Nancy D. PerrierEmail author
ASO Author Reflections



The authors have no conflicts of interest to disclose.


  1. 1.
    Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocr Metab. 2006;91(6):2027–37.CrossRefPubMedGoogle Scholar
  2. 2.
    Zou H, McGarry TJ, Bernal T, Kirschner MW. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science. 1999;285(5426): 418–22.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Tfelt-Hansen J, Kanuparthi D, Chattopadhyay N. The emerging role of pituitary tumor transforming gene in tumorigenesis. Clin Med Res. 2006;4(2):130–7.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Vlotides G, Eigler T, Melmed S. Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr Rev. 2007;28(2):165–86.CrossRefPubMedGoogle Scholar
  5. 5.
    Romero Arenas MA, Whitsett TG, Aronova A, et al. Protein expression of PTTG1 as a diagnostic biomarker in adrenocortical carcinoma. Ann Surg Oncol. 2018;25(3):801–7.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Minerva Angélica Romero Arenas
    • 1
    • 2
  • Nancy D. Perrier
    • 1
    Email author
  1. 1.The University of Texas MD Anderson Cancer CenterHoustonUSA
  2. 2.The University of Texas Rio Grande ValleyEdinburgUSA

Personalised recommendations